Targeted therapy outcomes in acrodermatitis continua of Hallopeau: A systematic reviewOA
Dear Editor,Acrodermatitis continua of Hallopeau(ACH),a rare and chronic variant of pustular psoriasis,is characterized by atrophic skin changes,sterile pustules,onychodystrophy,and osteolysis of the distal phalanges of the fingers and toes.Given the absence of international consensus guidelines and comprehensive clinical studies of high methodological rigor,the management of ACH primarily relies on antipsoriatic therapeutic approaches and empirical evidence derived from scattered case reports.With the development of biologics and small-molecule drugs,targeted therapies hold some promise for the future of its successful management[1].Here we summarize treatment outcomes of targeted therapies for ACH.
Chaojing Zhou;Yiyun Hou;Yufei Wang;Jiliang Lu;Yamei Gao;Zhiqiang Yin
Department of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,ChinaDepartment of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,ChinaDepartment of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,ChinaDepartment of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,ChinaDepartment of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,ChinaDepartment of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China
临床医学
dermatitisdrugsdystrophy
《Journal of Biomedical Research》 2024 (6)
P.640-642,3
supported by the National Natural Science Foundation of China(Grant Nos.82073439 and 82373475).
评论